Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine mouthwash for prevention of HSCT-induced oral mucositis
IRCT20140818018842N42Phase 3Completed
- Sponsor
- Hematology, Oncology and Stem Cell Transplantation Research Center
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stomatitis comparing N-acetylcysteine mouthwash with Placebo mouthwash (2 arms). Primary endpoints: Incidence and severity of oral mucositis, Length of hospitalization after engraftment and 2 more. Started Sep 2024; status: completed.
02
Drugs
acetylcysteine
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20140818018842N42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N42.